Dr.Shoumya Jyoti Datta Mazumder
Purpose: To correlate improvement in key parameters with that of vision related quality of life following intravitreal Ranibizumab injection.Methods: A prospective, hospital based observational study of 52 eyes of 49 patients underwent 1.25mg intravitreal Ranibizumab injection monotherapy as needed, from January ’16 to March ’17 in Eastern India. Measurements of LogMAR best corrected visual acuity and central macular thickness using optical coherence tomography before and 3 weeks after final injection. National Eye Institute Visual Function Questionnaire (VFQ-25) is scored before and after final injection. Results: Correlation between improvement of BCVA and vision related QOL and the same between improvement of BCVA and central macular thickness were statistically significant (p-value 0.034 and 0.0076 respectively).Conclusion: This study shows there is strong correlation between the functional improvement of vision and quality of life following Ranibizumab injection.
Leave a Comment